NCT07049289Active, not recruiting
Telemonitoring in Arterial Hypertension
Randomized Trial for Telemedical Support Versus Standard Treatment to Control Arterial Hypertension
Source: ClinicalTrials.gov · Last updated 3 Jul 2025
Brief summary (registry, in English)
Prospective, randomized trial to assess the effects of a telemedical approach of antihypertensive treatment in comparison with standard care. Total patient number: 60 patients. * Intervention group: biweekly telephone calls * Control group: standard of care
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 25 Jun 2025
- Start date
- 13 Dec 2023
- Primary completion date
- 9 Mar 2025
- Lead sponsor
- Heart Center Leipzig - University Hospital
- Diseases
- High blood pressure
- NCT number
- NCT07049289
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 13 Dec 2023 to the primary completion date, 9 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Pregnancy
- Participation in other randomized trials
- Patients under legal supervision or guardianship
Who the study is looking for
- Confirmed arterial hypertension with systolic or diastolic blood pressure \>140/90 mmHg in standardized office blood pressure measurement
- Treatment with 1 to ≤4 antihypertensive drug classes
- Age \>18 years
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Heart Centre Leipzig Coordinator of this site? Confirm its status | Leipzig | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.